t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs
2015 · Blood Cancer Journal · 43 citations
https://doi.org/10.1038/bcj.2015.6
S
Shin‐ichi Fuchida
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
114
Papers
697
Citations
15
h-index
22
i10-index
Shin‐ichi Fuchida is an academic researcher from Kyoto Medical Center. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Peptidase Inhibition and Analysis. The author has an h-index of 15, co-authored 97 publications.
ORCID: 0000-0002-4147-9113Papers by this author
worksPrimary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021)
2024 · International Journal of Hematology · 7 citations
https://doi.org/10.1007/s12185-024-03754-8
Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry
2018 · Leukemia Research Reports · 4 citations
https://doi.org/10.1016/j.lrr.2018.07.001
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients
2024 · Cancer Immunology Immunotherapy · 2 citations
https://doi.org/10.1007/s00262-024-03711-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat